Last Updated:
July 2, 2009



 

  • Rothman KJ, Louik C. Oral contraceptives and birth defects. N Engl J Med 1978;299:522-4.
  • Delzell ES, Louik C, Monson RR, Lewis J. Mortality and cancer morbidity in the tire industry. Am J Indust Med 1981;2:209-16.
  • Mitchell AA, Louik C, Lacouture P, Slone D, Goldman P, Shapiro S. Risks to children from CT Scan premedication. JAMA 1982;247:2385-8.
  • Rosenberg L, Mitchell AA, Parsells J, Pashayan H, Louik C, Shapiro S. Oral clefts in relation to diazepam use during pregnancy. N Engl J Med 1983;309:1282-5.
  • Mitchell AA, Schwingl PJ, Rosenberg L, Louik C, Shapiro S. Birth defects in relation to Bendectin use in pregnancy: 2. Pyloric stenosis. Am J Obstet Gynecol 1983;147:737-42.
  • Louik C, Mitchell AA, Werler MM, Hanson J, Shapiro S. Maternal exposure to spermicides in relation to certain birth defects. N Engl J Med 1987;317:474-8.
  • Werler MM, Louik C, Shapiro S, Mitchell AA. Ovulation induction and risk of neural tube defects. Lancet 1994;344:445-6.
  • Werler MM, Louik C, Shapiro SS, Mitchell AA. Prepregnant weight in relation to risk of neural tube defects. JAMA 1996;275:1089-92.
  • Louik C, Frumkin H, Ellenbecker MJ, Goldman RH, Werler MM, Mitchell AA. Use of a job-exposure matrix to assess occupational exposures in relation to birth defects. J Occup Environ Med 2000;42:693-703.
  • Louik C, Werler MM, Mitchell AA. Erythromycin use during pregnancy in relation to pyloric stenosis. Am J Obstet Gynecol 2002;186:288-90.
  • Werler MM, Louik C, Mitchell AA. Epidemiologic analysis of maternal factors and amniotic band defects. Birth Defects Res (Part A) 2003;67:68-72.
  • Louik C, Lacouture PG, Mitchell AA, Kauffman R, Lovejoy FH, Yaffe SJ, Shapiro S. A study of adverse reaction algorithms in a drug surveillance program. Clin Pharmacol Ther 1985;38:183-7.
  • Louik C, Mitchell AA, Epstein MF, Shapiro S. Risk factors for neonatal hyperglycemia associated with 10% dextrose infusion. Am J Dis Child 1985;139:783-6.
  • Lesko S, Mitchell AA, Epstein MF, Louik C, Giacoia GP, Shapiro S. Heparin use as a risk factor for intraventricular hemorrhage in low-birth-weight infants. N Engl J Med 1986;314:1156-60.
  • Mitchell AA, Van Bennekom C, Louik C. A pregnancy-prevention program in women of childbearing age receiving isotretinoin. N Engl J Med 1995;333:101-6.
  • Rosenberg L, Louik C, Shapiro S. Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma. Cancer 1998;82:2326-33.
  • Lesko SM, Louik C, Vezina R, Rosenberg L, Shapiro S. Vasectomy and prostate cancer. J Urol 1999,161:1848-53.
  • Coogan PF, Rosenberg L, Louik C, Zauber AG, Stolley PD, Strom BL, Shapiro S. NSAIDs and risk of colorectal cancer according to presence or absence of family history of the disease. Cancer Causes Control 2000;11:249-55.
  • Prihartono N, Palmer JR, Louik C, Shapiro S, Rosenberg L. A case-control study of use of postmenopausal female hormone supplements in relation to the risk of large bowel cancer. Cancer Epidemiol Biomarkers Prev 2000;9:443-7.
  • Louik C, Frumkin H, Ellenbecker MJ, Goldman RH, Werler MM, Mitchell AA. Use of a job-exposure matrix to assess occupational exposures in relation to birth defects. J Occup Environ Med 2000;42:693-703.
  • Lesko SM, Louik C, Vezina RM, Mitchell AA. Asthma morbidity following the short-term use of ibuprofen in children. Pediatrics 2002;109:e20 (electronic edition).
  • Louik C, Werler MM, Mitchell AA. Erythromycin use during pregnancy in relation to pyloric stenosis. Am J Obstet Gynecol 2002;186:288-90.
  • TW de Jong-van den Berg L, Hernández-Díaz S, Werler MM, Louik C, Mitchell AA. Trends and predictors of folic acid awareness and periconceptional use in pregnant women. Am J Obstet Gynecol 2005;192:121-8.
  • Chambers CD, Hernández-Díaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006;354(6):579-87.
  • Louik C, Hernández-Díaz S, Werler MM, Mitchell AA. Nausea and vomiting of pregnancy: Maternal characteristics and risk factors. Paediatr Perinat Epidemiol 2006;20:270-278.
  • Meijer WM, Werler MM, Louik C, Hernández-Díaz S, TW de Jong-van den Berg L, Mitchell AA. Can folic acid protect against congenital heart defects in Down syndrome? Birth Defects Res A Clin Mol Teratol 2006;76(10):714-7.
  • Louik C, Lin AE, Werler MM, Hernández-Díaz S , Mitchell AA. First-trimester use of Selective Serotonin-Reuptake Inhibitors and the risk of birth defects. N Engl J Med 2007;356:2675-83.





General Information

Publications


Email: clouik@bu.edu